Challenges in Diabetes Technology Supply Chains Amid Economic Pressures
The diabetes technology supply chain is experiencing mounting pressure from various economic factors, including tariffs, inflation, and changing geopolitical dynamics. These challenges are influencing where diabetes devices are manufactured, their pricing, and ultimately, the availability of these products for patients. On August 18, GlobalData Healthcare analysts Dr. Andrew Thompson and Charlie Whelan will conduct a webinar titled "Lifting the Lid on the Diabetes Tech Supply Chain," which will delve into the impact of these challenges.
During the webinar, Thompson and Whelan will utilize revenue and volume data from the diabetes device market to illustrate how macroeconomic forces affect both commercial outcomes and patient experiences. They will discuss how the globalized nature of manufacturing in the diabetes device sector exposes it to risks associated with tariffs and inflation. Additionally, the analysts will examine current revenue and volume flows within the market and the interplay between gate pricing and macroeconomic conditions.
Market Reading & Resources
Sponsor funding complete. Trade on.
As geopolitical uncertainties continue, the webinar will assess the implications of these factors for manufacturers, payers, and patients alike. This discussion aims to provide insights into how market challenges are reshaping pricing and production dynamics in the diabetes technology supply chain, offering valuable information for stakeholders in the industry.




